Microbial Evaluation of Sputum of Cystic Fibrosis Patients

Author(s):
Qamartaj KhanbabaeiQamartaj Khanbabaei1, Majid Reza  AkbarizadehMajid Reza Akbarizadeh2,*, S. Ahmad TabatabaeiS. Ahmad Tabatabaei1, Alireza FahimzadAlireza Fahimzad1
1Department of Pediatrics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Department of Pediatrics, Zabol University of Medical Sciences, Zabol, Iran
*Corresponding Author: Department of Pediatrics, Zabol University of Medical Sciences, Zabol, Iran Email: [email protected]

Zahedan Journal of Research in Medical Sciences:Vol. 14, issue 4; e93474
Published online:Jul 27, 2011
Article type:Research Article
Received:Sep 17, 2010
Accepted:Oct 13, 2010
How to Cite:Khanbabaei Q, Akbarizadeh MR, Tabatabaei SA, Fahimzad A. Microbial Evaluation of Sputum of Cystic Fibrosis Patients. Zahedan J Res Med Sci. 2012;14(4):e93474. doi:

Abstract

Background: Cystic fibrosis disease is a common hereditary autosomal recessive disorder in which loss of lung function caused by infectious factors is the most common cause of the patient’s death. In this study, the microbes in sputum of the cystic fibrosis patients have been studied during relapses of the disease.
Materials and Methods: In this cross-sectional study, 129 sputum cultures of the patients with cystic fibrosis, who were hospitalized in Mofid Children's Hospital in Tehran during 2004-2009 with relapse of disease, were studied. The data were collected through census method and based on the information concerning (gender, age, type of germ and the appropriate antibiotics).
Results: The most common germs in the sputum of these patients are Pseudomonas aeruginosa (approximately 36%) and then respectively klebsiella (13%), Staphylococcus aureus (9.3%) and Streptococcus pneumoniae (5.4%). Examination of antibiogram showed that these germs give an appropriate response to antibiotics such as Ceftazidime, vancomycin, imipenem, ciprofloxacin, azithromycin, rifampin and largely to aminoglycosides.
Conclusion: Considering the more prevalence of Pseudomonas aeruginosa, combined therapy with ceftazidime or imipenem along with aminoglycoside and further treatment with oral azithromycin are recommended. More studies in this area are necessary.

Fulltext

The full text of this article is available on the PDF file.

References

  • 1.
    The References of this article are available on the PDF file.

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

14
Aug
2012

Microbial Colonization and Drug Resistance in Patients with Cystic Fibrosis

Soheila Khalilzadeh,
Mohamad Boloursaz,
Nooshin Baghaie,
Elaheh Heydarian Fard,
Maryam Hassanzad,
Habib Emami

Khalilzadeh S, Boloursaz M, Baghaie N, Heydarian Fard E, Hassanzad M, et al. Microbial Colonization and Drug Resistance in Patients with Cystic Fibrosis. J Compr Ped. 2012;3(1):25-28. doi: https://doi.org/10.17795/compreped-6944

7
Oct
2024
Arch Pediatr Infect Dis

Microbial Colonization Patterns and Prognostic Factors in Cystic Fibrosis Patients: A Comprehensive Assessment

Seyed Ahmad Tabatabaii,
Ebrahim Tabiee,
Amir Reza Bahadori,
Aref Ghanaatpisheh,
Mahmoud Hajipour,
Nazanin Farahbakhsh

Tabatabaii SA, Tabiee E, Bahadori AR, Ghanaatpisheh A, Hajipour M, et al. Microbial Colonization Patterns and Prognostic Factors in Cystic Fibrosis Patients: A Comprehensive Assessment. Arch Pediatr Infect Dis. 2024;12(4):e147162. doi: https://doi.org/10.5812/apid-147162

21
Jul
2025
Jundishapur J Microbiol

Investigation of the Prevalence of Microbial Agents and Antibacterial Response in Pediatric with Cystic Fibrosis

Manijeh Khalili,
Touran Shahraki,
Alireza Teimouri,
Hossein Ansari,
Ahmad Ghanbari

Khalili M, Shahraki T, Teimouri A, Ansari H, Ghanbari A. Investigation of the Prevalence of Microbial Agents and Antibacterial Response in Pediatric with Cystic Fibrosis. Jundishapur J Microbiol. 2025;18(8):e161128. doi: https://doi.org/10.5812/jjm-161128

3
Aug
2019
Archives of Pediatric Infectious Diseases

Molecular Identification of Gram-Negative Bacteria in Respiratory Samples of Cystic Fibrosis Patients from a Children Referral Hospital in Tehran

Leila Azimi,
Roxana Mansour Ghanaiee,
Mehdi Shirdust,
Ahmad Moein Karimi,
Shahnaz Armin,
Sedigheh Rafiei Tabatabaei
,et al.

Azimi L, Mansour Ghanaiee R, Shirdust M, Karimi AM, Armin S, et al. Molecular Identification of Gram-Negative Bacteria in Respiratory Samples of Cystic Fibrosis Patients from a Children Referral Hospital in Tehran. Arch Pediatr Infect Dis. 2019;7(3):e64834. doi: https://doi.org/10.5812/pedinfect.64834

1
Nov
2013

New Treatment Approaches of Pseudomonas aeruginosa Infection in Cystic Fibrosis Lung Disease

Marisa Costa Gaspar,
Alberto António Caria Canelas Pais,
João José Simões de Sousa

Gaspar MC, Pais AACC, Sousa JJSD. New Treatment Approaches of Pseudomonas aeruginosa Infection in Cystic Fibrosis Lung Disease. J Compr Ped. 2013;4(4):203-4. doi: https://doi.org/10.17795/compreped-13822

Download PDF134.48 KB
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles